Arkolith/Insider Trading/MBX/Form 4

Yang Rick

10% OwnerMBX Biosciences, Inc. (MBX) · full profile →Form 4 · filed Sep 17, 2024
Net Buying
Open-Market Buys
$8.0M
Open-Market Sells
$0
Net Open-Market Flow
$8.0M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 16, 2024Conversion(C)1.0M——1.0M
Sep 16, 2024Buy(P)500K$16.00$8.0M3.6M
Sep 16, 2024Conversion(C)2.1M——3.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 16, 2024Conversion(C)12.3M——0
Sep 16, 2024Conversion(C)25.1M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-107542) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML